查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1464904

血液凝固檢驗市場：按產品類型、測試類型、最終用戶分類 - 2024-2030 年全球預測

Coagulation Testing Market by Product (Consumables, Instruments), Test Type (Activated Partial Thromboplastin Time, Prothrombin Time, Thrombin Time), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

血液凝固檢驗市場規模預計2023年為46.2億美元，2024年達50.7億美元，預計2030年將達到89.6億美元，複合年成長率為9.92%。

血液凝固檢驗涉及一系列旨在評估血液正常凝固能力的診斷程序。這些檢查對於診斷和治療影響血液凝固的各種疾病至關重要，例如血友病、血栓症和肝臟疾病。監測接受抗凝血治療的患者也很重要，以確保安全有效的治療結果。心血管和血液疾病的盛行率不斷增加，導致擴大採用血液凝固檢驗。此外，世界人口老化，血液相關疾病的風險更高，也顯著增加了對血液凝固檢驗的需求。然而，血液凝固檢驗設備的高成本和新設備核准的嚴格監管要求正在推遲產品上市並影響市場動態。儘管面臨這些挑戰，新興國家仍在增加對醫療基礎設施的投資，未來的成長是可期的。此外，旨在引入創新且高效的 KEYWORD 解決方案的研發活動正在進行中，並且預計會出現新的擴展途徑。

主要市場統計
基準年[2023] 46.2億美元
預測年份 [2024] 50.7億美元
預測年份 [2030] 89.6億美元
複合年成長率（%） 9.92%

更多採用自動化設備，以提高產品血液凝固檢驗的效率和擴充性

血液凝固檢驗中的耗材包括試劑、試紙等血液凝固檢驗必需的一次性材料。這些對於準確檢測和測量凝血時間、因子和其他相關參數至關重要。血液凝固檢驗設備範圍從基本的手動設備到全自動系統。這些設備用於各種測試，包括凝血酶原時間 (PT) 和活化部份凝血活酵素時間(aPTT)。手動或自動系統之間的選擇通常基於實驗室執行的測試量和所需測試的複雜性。

最終用戶：擴大採用支援遠端患者監護的家庭血液凝固檢驗套件

臨床實驗室代表了血液凝固檢驗市場的重要部分。這些設施需要全面、先進的血液凝固檢驗解決方案，為各種出血和凝血障礙提供準確、可靠的診斷服務。臨床實驗室更喜歡能夠高效處理大量檢體的高通量凝血分析儀。人們越來越重視以患者為中心的護理，並且需要持續監測接受抗凝血治療的患者，這推動了對居家血液凝固檢驗檢測解決方案的需求。家用檢測套組對於尋求便利且對日常生活影響最小的患者很有吸引力。醫院需要多種血液凝固檢驗能力，以滿足從急診室到凝血門診等各科室的需求。該產業青睞多功能、快速的凝血分析儀，能夠在急診環境中快速做出決策。

區域洞察

血液凝固檢驗的採用在美洲越來越多，尤其是在心血管疾病盛行率高且人口老化的北美。美國的採用率很高，得益於先進的醫療基礎設施和優惠的報銷政策。歐洲、中東和非洲地區的血液凝固檢驗市場呈現多樣化的情況，其中歐洲的採用率很高。歐洲的成長得益於擴大採用現場檢測設備以實現更快、更有效率的診斷，以及強大的醫療保健系統和患者的高水平意識。由於政府和非政府組織改善醫療設施的舉措，中東和非洲正在經歷適度成長。在快速發展的醫療基礎設施和龐大的患者群的推動下，亞太地區預計將成為最大的血液凝固檢驗市場。在中國和印度等國家，隨著中產階級人口的成長和對醫療改革興趣的增加，血液凝固檢驗的採用正走在最前線。此外，該地區不斷成長的開發負擔得起的測試解決方案的研發活動預計也將提振該地區的市場。

FPNV定位矩陣

FPNV定位矩陣對於評估血液凝固檢驗市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對血液凝固檢驗市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.血液凝固檢驗市場規模及預測是多少？

2.在血液凝固檢驗市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.血液凝固檢驗市場的技術趨勢和法規結構是什麼？

4.血液凝固檢驗市場主要廠商的市場佔有率是多少？

5.進入血液凝固檢驗市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球凝血病患病率增加
      • 政府宣傳活動，提高人們對危及生命的血栓的認知
    • 抑制因素
      • 血液凝固檢驗缺乏報銷
    • 機會
      • 血液凝固檢驗技術的進展
      • 居家照護血液凝固檢驗的出現
    • 任務
      • 血液凝固檢驗的技術限制與不準確性
  • 市場區隔分析
    • 產品：更多採用自動化設備，以實現血液凝固檢驗的效率和擴充性
    • 最終用戶：擴大採用支援遠端患者監護的家庭血液凝固檢驗套件
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章血液凝固檢驗市場：依產品

  • 消耗品
  • 裝置

第7章按測試類型血液凝固檢驗市場

  • 活化部份凝血活酵素時間
  • 凝血酶原時間
  • 凝血酶時間

第 8 章血液凝固檢驗市場：依最終用戶分類

  • 臨床實驗室
  • 家庭測試
  • 醫院

第9章 北美、南美血液凝固檢驗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太血液凝固檢驗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲血液凝固檢驗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 羅氏推出三款新的 Xa 因子抑制劑血液凝固檢驗，以滿足不斷成長的患者需求
    • HORIBA UK 在 2023 年 IBMS 會議上宣布推出新型全自動凝血分析儀
    • Diagnostica Stago 凝血分析儀獲得 FDA 510(k) 許可
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-BF590674206B

[192 Pages Report] The Coagulation Testing Market size was estimated at USD 4.62 billion in 2023 and expected to reach USD 5.07 billion in 2024, at a CAGR 9.92% to reach USD 8.96 billion by 2030.

Coagulation testing encompasses a range of diagnostic procedures aimed at assessing the blood's ability to clot properly. These tests are critical in diagnosing and managing various conditions that affect the blood's clotting capability, such as hemophilia, thrombosis, and liver disease. They are also essential in monitoring patients on anticoagulation therapy to ensure safe and effective treatment outcomes. The rising prevalence of cardiovascular diseases and blood disorders has increased the adoption of coagulation testing. Additionally, the aging global population at higher risk of blood-related disorders also significantly raises the need for coagulation testing. However, the high cost of coagulation testing devices and stringent regulatory requirements for the new devices' approval delay product launches, affecting market dynamics. Despite these challenges, increasing investment in healthcare infrastructure in emerging economies provides a future growth prospect. Furthermore, ongoing research and development activities aiming to introduce innovative and efficient coagulation testing solutions are expected to offer new avenues for expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 4.62 billion
Estimated Year [2024] USD 5.07 billion
Forecast Year [2030] USD 8.96 billion
CAGR (%) 9.92%

Product: Rising deployment of automated instruments to achieve efficiency and scalability in coagulation testing

Consumables in coagulation testing include reagents, test strips, and other single-use materials integral to conducting a coagulation test. These are essential for accurately detecting and measuring blood clotting times, factors, and other related parameters. Coagulation testing instruments range from basic manual devices to fully automated systems. These machines are used for various tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), and more. The choice between manual and automated systems is generally based on the volume of tests a laboratory performs and the complexity of the tests required.

End-User: Growing adoption of home coagulation testing kits to support remote patient monitoring

Clinical laboratories represent a significant segment of the coagulation testing market. These facilities require comprehensive and advanced coagulation testing solutions to offer accurate and reliable diagnostic services for a variety of bleeding and clotting disorders. The preference in clinical laboratories leans towards high-throughput coagulation analyzers that can handle a large volume of samples efficiently. The demand for home testing solutions in coagulation testing has surged, driven by the increasing emphasis on patient-centered care and the need for continuous monitoring of patients on anticoagulation therapy. Home testing kits appeal to patients seeking convenience and minimal disruption to daily life. Hospitals require a diverse range of coagulation testing capabilities to cater to the needs of different departments, from emergency rooms to specialized coagulation clinics. The preference in this segment is for versatile and rapid coagulation analyzers that facilitate quick decision-making in acute care settings.

Regional Insights

In the Americas, coagulation testing is getting highly adopted owing to the high prevalence of cardiovascular diseases and an increasing aging population, particularly in North America. The United States showcases higher adoption, supported by advanced healthcare infrastructure and favorable reimbursement policies. The EMEA region presents diverse scenarios in the coagulation testing market, with Europe having a high adoption rate. The growth in Europe is spurred by the increasing adoption of point-of-care (POC) testing devices for faster and more efficient diagnosis, alongside strong healthcare systems and a higher level of patient awareness. The Middle East and Africa are witnessing gradual growth, with initiatives by governments and NGOs to improve healthcare facilities. Asia-Pacific is projected to be the biggest market for coagulation testing, driven by rapidly developing healthcare infrastructure and a large patient pool. Countries inclduing China and India are at the forefront of the adoption of coagulation testing, with their growing middle-class populations and increased focus on healthcare reform. Furthermore, the expanding research and development activities in the region to develop affordable testing solutions are expected to boost the market in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Coagulation Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Coagulation Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Coagulation Testing Market, highlighting leading vendors and their innovative profiles. These include A&T Corporation, Abbott Laboratories, Advin Health Care, Becton, Dickinson and Company, Beijing Succeeder Technology Inc., Bio Group Medical System SRL, Bio-Rad Laboratories, Inc., Coagulation Sciences LLC, Danaher Corporation, Drucker Diagnostics, LLC, F. Hoffmann-La Roche Ltd, Genrui Biotech Inc., Helena Laboratories Corporation, HORIBA, Ltd., Maccura Biotechnology Co., Ltd., Medtronic PLC, Mindray Bio-Medical Electronics Co., Ltd., Sekisui Chemical Co., Ltd., Shenzhen Micropoint Biotechnologies Co., Ltd., Siemens Healthineers AG, Stago Group, Sysmex Corporation, Thermo Fisher Scientific Inc., Trivitron Healthcare, and Tulip Diagnostics (P) Ltd.

Market Segmentation & Coverage

This research report categorizes the Coagulation Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
    • Instruments
  • Test Type
    • Activated Partial Thromboplastin Time
    • Prothrombin Time
    • Thrombin Time
  • End-User
    • Clinical Laboratories
    • Home Testing
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Coagulation Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Coagulation Testing Market?

3. What are the technology trends and regulatory frameworks in the Coagulation Testing Market?

4. What is the market share of the leading vendors in the Coagulation Testing Market?

5. Which modes and strategic moves are suitable for entering the Coagulation Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of coagulation disorders worldwide
      • 5.1.1.2. Government campaigns promoting awareness of life-threatening blood clots
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursements for coagulation testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in coagulation testing technologies
      • 5.1.3.2. Emergence of coagulation testing for homecare
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and inaccuracies of coagulation testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising deployment of automated instruments to achieve efficiency and scalability in coagulation testing
    • 5.2.2. End-User: Growing adoption of home coagulation testing kits to support remote patient monitoring
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Coagulation Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments

7. Coagulation Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Activated Partial Thromboplastin Time
  • 7.3. Prothrombin Time
  • 7.4. Thrombin Time

8. Coagulation Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinical Laboratories
  • 8.3. Home Testing
  • 8.4. Hospitals

9. Americas Coagulation Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Coagulation Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Coagulation Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Roche Launches Three New Factor Xa Inhibitor Coagulation Tests to Meet Growing Patient Need
    • 12.3.2. HORIBA UK to Introduce New Fully Automated Haemostasis Analysers at IBMS Congress 2023
    • 12.3.3. Diagnostica Stago Nabs FDA 510(k) Clearance for Coagulation Analyzers
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. COAGULATION TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. COAGULATION TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. COAGULATION TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COAGULATION TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL COAGULATION TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL COAGULATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL COAGULATION TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL COAGULATION TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL COAGULATION TESTING MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL COAGULATION TESTING MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL COAGULATION TESTING MARKET SIZE, BY THROMBIN TIME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL COAGULATION TESTING MARKET SIZE, BY THROMBIN TIME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL COAGULATION TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL COAGULATION TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOME TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOME TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023